These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 35305714)

  • 1. Pathways Involved in the Development of Vasculogenic Mimicry in Canine Mammary Carcinoma Cell Cultures.
    Guiraldelli GG; Prado MCM; de F Lainetti P; Leis-Filho AF; Kobayashi PE; Cury SS; Fonseca-Alves CE; Laufer-Amorim R
    J Comp Pathol; 2022 Apr; 192():50-60. PubMed ID: 35305714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors.
    Prado MCM; Macedo SAL; Guiraldelli GG; de Faria Lainetti P; Leis-Filho AF; Kobayashi PE; Laufer-Amorim R; Fonseca-Alves CE
    Front Oncol; 2019; 9():1445. PubMed ID: 31921690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of three-dimensional canine osteosarcoma cell lines showing vasculogenic mimicry and evaluation of biological properties after treatment with 17-AAG.
    Massimini M; De Maria R; Malatesta D; Romanucci M; D'Anselmo A; Della Salda L
    Vet Comp Oncol; 2019 Sep; 17(3):376-384. PubMed ID: 31006970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability
    de Faria Lainetti P; Brandi A; Leis Filho AF; Prado MCM; Kobayashi PE; Laufer-Amorim R; Fonseca-Alves CE
    Front Vet Sci; 2020; 7():583874. PubMed ID: 33195606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines.
    Barreno L; Cáceres S; Alonso-Diez Á; Vicente-Montaña A; García ML; Clemente M; Illera JC; Peña L
    BMC Cancer; 2019 Jul; 19(1):750. PubMed ID: 31362745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology.
    Massimini M; Romanucci M; De Maria R; Della Salda L
    Front Vet Sci; 2021; 8():722432. PubMed ID: 34631854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
    Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma.
    Almahmoudi R; Salem A; Hadler-Olsen E; Svineng G; Salo T; Al-Samadi A
    Cancer Sci; 2021 Jun; 112(6):2223-2232. PubMed ID: 33743555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.
    Hori A; Shimoda M; Naoi Y; Kagara N; Tanei T; Miyake T; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res; 2019 Aug; 21(1):88. PubMed ID: 31387614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of vasculogenic mimicry in sebaceous carcinoma of the eyelid.
    Xu X; Jia R; Zhou Y; Song X; Fan X
    Acta Ophthalmol; 2010 Aug; 88(5):e160-4. PubMed ID: 20553231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
    Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
    J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
    Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
    Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin promotes vasculogenic mimicry and invasion via Notch‑1‑activated epithelial‑to‑mesenchymal transition in syncytiolization of trophoblast cells in choriocarcinoma.
    Xue Y; Sun R; Zheng W; Yang L; An R
    Int J Oncol; 2020 May; 56(5):1129-1139. PubMed ID: 32319581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
    Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
    Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma.
    Itzhaki O; Greenberg E; Shalmon B; Kubi A; Treves AJ; Shapira-Frommer R; Avivi C; Ortenberg R; Ben-Ami E; Schachter J; Besser MJ; Markel G
    PLoS One; 2013; 8(2):e57160. PubMed ID: 23451174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo.
    Yao N; Ren K; Jiang C; Gao M; Huang D; Lu X; Lou B; Peng F; Yang A; Wang X; Ni Y; Zhang J
    Tumour Biol; 2015 Nov; 36(11):8499-510. PubMed ID: 26026583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
    Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
    Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer.
    Li Y; Sun B; Zhao X; Wang X; Zhang D; Gu Q; Liu T
    J Cell Mol Med; 2017 Dec; 21(12):3741-3751. PubMed ID: 28766880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.